Suppr超能文献

阿尔茨海默病患者额叶皮质病变过程中的氧化应激。

Oxidative stress in the progression of Alzheimer disease in the frontal cortex.

机构信息

Sanders-Brown Center on Aging, University of Kentucky, Lexington, Kentucky 40536-0230, USA.

出版信息

J Neuropathol Exp Neurol. 2010 Feb;69(2):155-67. doi: 10.1097/NEN.0b013e3181cb5af4.

Abstract

We investigated oxidative stress in human postmortem frontal cortexfrom individuals characterized as mild cognitive impairment (n= 8), mild/moderate Alzheimer disease (n = 4), and late-stage Alzheimer disease (n = 9). Samples from subjects with no cognitive impairment (n = 10) that were age- and postmortem interval-matched with these cases were used as controls. The short postmortem intervalbrain samples were processed for postmitochondrial supernatant, nonsynaptic mitochondria, and synaptosome fractions. Samples were analyzed for several antioxidants (glutathione, glutathione peroxidase, glutathione reductase, glutathione-S-transferase, glucose-6-phosphate dehydrogenase, superoxide dismutase, catalase) and the oxidative marker, thiobarbituric acid reactive substances. The tissue was also analyzed for possible changes in protein damage using neurochemical markers for protein carbonyls, 3-nitrotyrosine, 4-hydroxynonenal, andacrolein. All 3 neuropil fractions (postmitochondrial supernatant, mitochondrial, and synaptosomal) demonstrated significant disease-dependent increases in oxidative markers. The highest changes were observed in the synaptosomal fraction. Both mitochondrial and synaptosomal fractions had significant declines in antioxidants (glutathione, glutathione peroxidase, glutathione-S-transferase, and superoxide dismutase). Levels of oxidative markers significantly correlated with Mini-Mental Status Examination scores. Oxidative stress was more localized to the synapses, with levels increasing in a disease-dependent fashion. These correlations implicate an involvement of oxidative stress in Alzheimer disease-related synaptic loss.

摘要

我们研究了来自轻度认知障碍(n=8)、轻度/中度阿尔茨海默病(n=4)和晚期阿尔茨海默病(n=9)患者的人死后额皮质中的氧化应激。将与这些病例年龄和死后间隔匹配的无认知障碍(n=10)受试者的样本用作对照。对这些短死后间隔的脑组织样本进行了线粒体后上清液、非突触线粒体和突触体部分的处理。对几种抗氧化剂(谷胱甘肽、谷胱甘肽过氧化物酶、谷胱甘肽还原酶、谷胱甘肽-S-转移酶、葡萄糖-6-磷酸脱氢酶、超氧化物歧化酶、过氧化氢酶)和氧化标志物硫代巴比妥酸反应物质进行了分析。还使用神经化学标志物对蛋白质羰基、3-硝基酪氨酸、4-羟基壬烯醛和丙烯醛来分析组织中可能发生的蛋白质损伤变化。所有 3 种神经突(线粒体后上清液、线粒体和突触体)均显示出与疾病相关的氧化标志物显著增加。突触体部分的变化最大。线粒体和突触体部分的抗氧化剂(谷胱甘肽、谷胱甘肽过氧化物酶、谷胱甘肽-S-转移酶和超氧化物歧化酶)均显著下降。氧化标志物的水平与简易精神状态检查评分显著相关。氧化应激更局限于突触,其水平呈疾病依赖性增加。这些相关性表明氧化应激参与了阿尔茨海默病相关的突触丢失。

相似文献

1
Oxidative stress in the progression of Alzheimer disease in the frontal cortex.
J Neuropathol Exp Neurol. 2010 Feb;69(2):155-67. doi: 10.1097/NEN.0b013e3181cb5af4.
3
Association between frontal cortex oxidative damage and beta-amyloid as a function of age in Down syndrome.
Biochim Biophys Acta. 2012 Feb;1822(2):130-8. doi: 10.1016/j.bbadis.2011.10.001. Epub 2011 Oct 8.
6
Antioxidant intervention attenuates oxidative stress in children and teenagers with Down syndrome.
Res Dev Disabil. 2014 Jun;35(6):1228-36. doi: 10.1016/j.ridd.2014.03.013. Epub 2014 Mar 28.
8
Effect of blueberry pretreatment on diethylnitrosamine-induced oxidative stress and liver injury in rats.
Environ Toxicol Pharmacol. 2013 Sep;36(2):529-538. doi: 10.1016/j.etap.2013.05.014. Epub 2013 Jun 10.
9
Platelets mirror changes in the frontal lobe antioxidant system in Alzheimer's disease.
Alzheimers Dement. 2025 Apr;21(4):e70117. doi: 10.1002/alz.70117.
10
Oxidative stress in Alzheimer patients in different stages of the disease.
Curr Med Chem. 2006;13(9):1075-83. doi: 10.2174/092986706776360978.

引用本文的文献

2
Insights into targeted ferroptosis in mechanisms, biology, and role of Alzheimer's disease: an update.
Front Aging Neurosci. 2025 Jul 21;17:1587986. doi: 10.3389/fnagi.2025.1587986. eCollection 2025.
5
2D and 3D Models of Alzheimer's Disease: Investigating Neuron-like Cells in Oxidative Environments.
ACS Omega. 2025 Jun 16;10(25):27501-27514. doi: 10.1021/acsomega.5c03306. eCollection 2025 Jul 1.
6
Melatonin Supplementation in Alzheimer's disease: The Potential Role in Neurogenesis.
Mol Neurobiol. 2025 May 29. doi: 10.1007/s12035-025-05095-x.
7
Research Progress on Phytochemicals from Mulberry with Neuroprotective Effects: A Review.
Pharmaceuticals (Basel). 2025 May 8;18(5):695. doi: 10.3390/ph18050695.
10
Neuroferroptosis in health and diseases.
Nat Rev Neurosci. 2025 May 19. doi: 10.1038/s41583-025-00930-5.

本文引用的文献

2
Oxidative stress and modification of synaptic proteins in hippocampus after traumatic brain injury.
Free Radic Biol Med. 2008 Aug 15;45(4):443-52. doi: 10.1016/j.freeradbiomed.2008.04.038. Epub 2008 May 3.
3
Dendritic spine loss and synaptic alterations in Alzheimer's disease.
Mol Neurobiol. 2008 Feb;37(1):73-82. doi: 10.1007/s12035-008-8018-z. Epub 2008 Apr 26.
4
Brain oxidative stress in a triple-transgenic mouse model of Alzheimer disease.
Free Radic Biol Med. 2008 Jun 15;44(12):2051-7. doi: 10.1016/j.freeradbiomed.2008.03.012. Epub 2008 Mar 28.
5
Amyloid flirting with synaptic failure: towards a comprehensive view of Alzheimer's disease pathogenesis.
Eur J Pharmacol. 2008 May 6;585(1):109-18. doi: 10.1016/j.ejphar.2007.11.083. Epub 2008 Mar 4.
6
Soluble oligomers of the amyloid beta-protein impair synaptic plasticity and behavior.
Behav Brain Res. 2008 Sep 1;192(1):106-13. doi: 10.1016/j.bbr.2008.02.016. Epub 2008 Feb 17.
7
Nucleic acid oxidation in Alzheimer disease.
Free Radic Biol Med. 2008 Apr 15;44(8):1493-505. doi: 10.1016/j.freeradbiomed.2008.01.002. Epub 2008 Jan 18.
9
High cyclophilin D content of synaptic mitochondria results in increased vulnerability to permeability transition.
J Neurosci. 2007 Jul 11;27(28):7469-75. doi: 10.1523/JNEUROSCI.0646-07.2007.
10
Damage to lipids, proteins, DNA, and RNA in mild cognitive impairment.
Arch Neurol. 2007 Jul;64(7):954-6. doi: 10.1001/archneur.64.7.954.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验